Neoadjuvant Study of Nab-paclitaxel Plus Carboplatin in Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: nab-paclitaxel
Sponsor: Shanghai Cancer Hospital, China